These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 1830133

  • 1. Cooperation between D1- and D2-dopamine receptors in the nucleus accumbens.
    Szmigielski A, Zalewska-Kaszubska J.
    Neuropharmacology; 1991 Mar; 30(3):259-66. PubMed ID: 1830133
    [Abstract] [Full Text] [Related]

  • 2. Effect of supersensitivity of pre- and postsynaptic dopamine receptors on the activity of endogenous inhibitor of cAMP dependent protein kinase in rat striatum.
    Szmigielski A, Szadowska A, Szmigielska H.
    Arch Int Pharmacodyn Ther; 1984 Dec; 272(2):214-24. PubMed ID: 6098230
    [Abstract] [Full Text] [Related]

  • 3. D1 and D2 dopamine receptor mediation of amphetamine-induced acetylcholine release in nucleus accumbens.
    Keys AS, Mark GP.
    Neuroscience; 1998 Sep; 86(2):521-31. PubMed ID: 9881866
    [Abstract] [Full Text] [Related]

  • 4. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA.
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [Abstract] [Full Text] [Related]

  • 5. Localization of dopamine receptor subtypes occupied by intra-accumbens antagonists that reverse cocaine-induced locomotion.
    Neisewander JL, O'Dell LE, Redmond JC.
    Brain Res; 1995 Feb 13; 671(2):201-12. PubMed ID: 7743209
    [Abstract] [Full Text] [Related]

  • 6. Neonatal dopamine lesion in the rat results in enhanced adenylate cyclase activity without altering dopamine receptor binding or dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein (DARPP-32) immunoreactivity.
    Luthman J, Lindqvist E, Young D, Cowburn R.
    Exp Brain Res; 1990 Feb 13; 83(1):85-95. PubMed ID: 1981564
    [Abstract] [Full Text] [Related]

  • 7. Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. I. 6-OHDA lesions of ascending mesencephalic dopaminergic pathways in the rat.
    Graham WC, Crossman AR, Woodruff GN.
    Brain Res; 1990 Apr 23; 514(1):93-102. PubMed ID: 2113410
    [Abstract] [Full Text] [Related]

  • 8. Role of N-methyl-D-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems.
    Singh NA, Bush LG, Gibb JW, Hanson GR.
    Brain Res; 1992 Feb 07; 571(2):260-4. PubMed ID: 1351780
    [Abstract] [Full Text] [Related]

  • 9. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG, Walters JR.
    Brain Res; 1987 Mar 10; 405(2):234-46. PubMed ID: 2952219
    [Abstract] [Full Text] [Related]

  • 10. The actions of (-)N-n-propylnorapomorphine and selective dopamine D1 and D2 receptor agonists to modify the release of [3H]dopamine from the rat nucleus accumbens.
    Barnes JM, Barnes NM, Costall B, Naylor RJ.
    Neuropharmacology; 1990 Apr 10; 29(4):327-36. PubMed ID: 1971430
    [Abstract] [Full Text] [Related]

  • 11. Striatal and nucleus accumbens D1/D2 dopamine receptors in neuroleptic catalepsy.
    Ossowska K, Karcz M, Wardas J, Wolfarth S.
    Eur J Pharmacol; 1990 Jul 03; 182(2):327-34. PubMed ID: 1975782
    [Abstract] [Full Text] [Related]

  • 12. Apomorphine-induced context-specific behavioural sensitization is prevented by the D1 antagonist SCH-23390 but potentiated and uncoupled from contextual cues by the D2 antagonist sulpiride.
    Dias FR, Carey RJ, Carrera MP.
    Psychopharmacology (Berl); 2010 Apr 03; 209(2):137-51. PubMed ID: 20177884
    [Abstract] [Full Text] [Related]

  • 13. Preferential vulnerability of nucleus accumbens dopamine binding sites to low-level lead exposure: time course of effects and interactions with chronic dopamine agonist treatments.
    Pokora MJ, Richfield EK, Cory-Slechta DA.
    J Neurochem; 1996 Oct 03; 67(4):1540-50. PubMed ID: 8858938
    [Abstract] [Full Text] [Related]

  • 14. Positive and negative interactions in the behavioural expression of D1 and D2 receptor stimulation in a model of Parkinsonism: role of priming.
    Morelli M, Fenu S, Cozzolino A, Di Chiara G.
    Neuroscience; 1991 Oct 03; 42(1):41-8. PubMed ID: 1830642
    [Abstract] [Full Text] [Related]

  • 15. Effect of dopamine D-1 and D-2 receptor selective drugs on dopamine release and metabolism in rat striatum in vivo.
    Zetterström T, Sharp T, Ungerstedt U.
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct 03; 334(2):117-24. PubMed ID: 2946964
    [Abstract] [Full Text] [Related]

  • 16. Dopamine receptor changes in response to prolonged treatment with L-dopa.
    Groppetti A, Flauto C, Parati E, Vescovi A, Rusconi L, Parenti M.
    J Neural Transm Suppl; 1986 Oct 03; 22():33-45. PubMed ID: 2946813
    [Abstract] [Full Text] [Related]

  • 17. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR, Hu XT, Galloway MP, White FJ.
    Synapse; 1989 Oct 03; 4(4):327-46. PubMed ID: 2532422
    [Abstract] [Full Text] [Related]

  • 18. Contralateral turning elicited by unilateral stimulation of dopamine D2 and D1 receptors in the nucleus accumbens of rats is due to stimulation of these receptors in the shell, but not the core, of this nucleus.
    Koshikawa N, Kitamura M, Kobayashi M, Cools AR.
    Psychopharmacology (Berl); 1996 Aug 03; 126(3):185-90. PubMed ID: 8876017
    [Abstract] [Full Text] [Related]

  • 19. Yawning is elicited by D2 dopamine agonists but is blocked by the D1 antagonist, SCH 23390.
    Serra G, Collu M, Gessa GL.
    Psychopharmacology (Berl); 1987 Aug 03; 91(3):330-3. PubMed ID: 2882540
    [Abstract] [Full Text] [Related]

  • 20. The effect of stimulation of pre- and postsynaptic dopamine receptors on the endogenous inhibitor of cAMP-dependent protein kinase.
    Szmigielski A, Kowner A.
    Arch Int Pharmacodyn Ther; 1984 Dec 03; 272(2):205-13. PubMed ID: 6098229
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.